Table 2.

Outcomes.

	All (245)	Single antiplatelet group (118)	Dual antiplatelet group (127)	p
Primary outcome
Recurrence of stroke within 90 days	8 (3.27)	4 (3.39)	4 (3.15)	0.916
Symptomatic intracerebral hemorrhage-no. (%)	3 (1.22)	2 (1.69)	1 (0.79)	0.610
Secondary outcomes
90-day mRS score	0 (0–1)	0 (0–1)	0 (0–1)	0.012
90-day mRS score 0–1	206 (84.08)	93 (78.81)	113 (88.98)	0.030
90-day mRS score 0–2	222 (90.61)	103 (87.29)	119 (93.70)	0.086
90-day mRS score 0–3	233 (95.10)	111 (94.07)	122 (96.06)	0.470
Early neurological deterioration no. (%)
3d after IVT	14 (5.71)	8 (6.78)	6 (4.72)	0.489
7d after IVT	13 (5.31)	8 (6.78)	5 (3.94)	0.321

mRS, modified Rankin Scale.